Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,417 | -92,287 | -62,734 | -44,206 | -20,653 |
| Depreciation Amortization | 63 | 50 | 23 | 13 | 6 |
| Accounts payable and accrued liabilities | -3,113 | 3,526 | 3,370 | -1,191 | -1,739 |
| Other Working Capital | -7,312 | 5,781 | 996 | -2,274 | -1,623 |
| Other Operating Activity | 5,733 | 7,373 | 5,233 | 7,492 | 2,951 |
| Operating Cash Flow | $-31,046 | $-75,557 | $-53,112 | $-40,166 | $-21,058 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,217 | -35,307 | -9,685 | -1,934 | -505 |
| Investing Cash Flow | $-20,217 | $-35,307 | $-9,685 | $-1,934 | $-505 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,063 | 212,487 | 168,720 | 130,759 | 108,710 |
| Financing Cash Flow | $13,063 | $212,487 | $168,720 | $130,759 | $108,710 |
| Exchange Rate Effect | -25 | -31 | -21 | -8 | -1 |
| Beginning Cash Position | 178,900 | 77,308 | 77,308 | 77,308 | 77,308 |
| End Cash Position | 140,675 | 178,900 | 183,210 | 165,959 | 164,454 |
| Net Cash Flow | $-38,225 | $101,592 | $105,902 | $88,651 | $87,146 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,046 | -75,557 | -53,112 | -40,166 | -21,058 |
| Capital Expenditure | -20,217 | -35,307 | -9,685 | -1,934 | -505 |
| Free Cash Flow | -51,263 | -110,864 | -62,797 | -42,100 | -21,563 |